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Targeting a DNA·RNA Hybrid DOI: 10.1002/anie.200((will be filled in by the editorial staff)) 
Probing the Molecular Recognition of a DNA·RNA Hybrid Duplex** 
Richard T. Wheelhouse,* Nichola C. Garbett, Niklaas J. Buurma and Jonathan B. Chaires. 
 
DNA·RNA hybrid duplexes are the nucleic acid structures least 
explored as targets in drug discovery. There is a dearth of model 
ligands displaying convincing structure or sequence selectivity; the 
secondary structures of the hybrid nucleic acid hosts are variable 
and complex[1, 2] Ligands selective for hybrid duplexes have 
potential therapeutic applications as telomerase and RNaseH 
inhibitors. 
 
Assays for investigating small molecule interactions with 
DNA·RNA hybrid duplexes have only recently been developed and 
described.[3] Herein their application to the discovery of a small 
molecule that specifically recognizes poly(dA)·poly(rU) is reported. 
An unexpected binding mode was uncovered, establishing a 
principle that extrapolations from pure DNA or RNA binding are 
invalid when considering DNA·RNA hybrid duplexes. 
 
Competition dialysis (Fig. 1) showed that the non-classical 
intercalator 1 bound preferentially to quadruplex and triplex DNA 
structures and to the hybrid duplex poly(dA)·poly(rU). In duplex 
binding, strong preferences for both backbone and base orientation 
were evident: association with the poly(dA)·poly(rU) hybrid duplex 
had ~20-fold preference over the equivalent RNA, 3-fold over DNA, 
and 7-fold over the alternative poly(rA)·poly(dT) hybrid. 
 
Relative binding preferences for duplex structures were confirmed 
in a melting of mixtures assay in which UV melting profiles were 
obtained for a mixture of all four A·T(U) duplexes in the absence 
and presence of low concentrations of ligand, Fig. 2.[3, 4] Significant 
shifting of the melting transition of the poly(dA)·poly(rU) hybrid 
was accompanied by a lesser shift in the DNA duplex melting curve 
at higher ligand loading. 
 
NN
SN S N
H H
1  
 
Figure 1. Competition dialysis data for compound 1, all data are the 
mean±SD of 3 separate determinations. 
 
Figure 2. Melting of mixtures data for the four A·T(U) duplexes (each 
10 µM(bp)) in the presence of increasing concentrations of ligand 1. 
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Figure 3. a) Reference CD spectra of the four A·T(U) duplexes; b) CD 
titration of ligand 1 into poly(dA)·poly(rU) duplex; c) Induced CD as a 
function of the [1] / [poly(dA)·poly(rU)]bp ratio; d) Job plot for mixtures 
of compound 1 with poly(dA)·poly(rU) at a constant 100 µM. e) CD 
titration of ligand 1 poly(dA)·[poly(dT)]2 triplex, the spectrum of the 
free nucleic acid is shown as a heavy line; f) induced CD as a function 
of the [1] / [poly(dA)·{poly(dT)}2]bt ratio. 
CD experiments (Fig. 3a–c) further elucidated the binding 
interaction. As ligand 1 was titrated into the hybrid solution, the 
intensity of nucleic acid ellipticity (244 and 275 nm) decreased but 
the envelope of the spectrum retained its starting shape: indicative of 
reduced chirality in the oligonucleotide (unwinding) due to 
intercalation, without alteration of the global conformation. 
Negative induced CD bands observed for the ligand (320 and 364.5 
nm, Figs 3b,c) were also consistent with intercalation.[5] 
Intercalation was confirmed by a preliminary analytical 
ultracentrifugation (AUC) experiment in which the sedimentation 
coefficient decreased upon ligand loading in a manner consistent 
with unwinding and lengthening of the duplex (Fig S2). Plots of 
induced CD intensity vs. ligand:base pair ratio (Fig. 3c) had an 
inflection at a ratio of 1:10 (at high ligand concentrations 
precipitation of the sample occurred). The 10 bp per ligand binding 
stoichiometry was confirmed by a Job plot (Fig. 3d).  
 
CD titration spectra using poly(dA)·[poly(dT)]2 triplex DNA, Fig. 
3e, reflected those obtained for the hybrid duplex, showing 
unwinding of the triplex and negative induced CD in the ligand (300, 
360.8, 328 nm). The inflection in the induced CD plots (Fig. 3f) 
occurred at a mixing ratio of 0.15, i.e. ~7 bt per ligand. 
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Isothermal titration calorimetry (ITC) probed thermodynamic details 
of the binding interaction. The thermogram for ligand dilution 
indicated disaggregation of the ligand; data analysis using an 
isosdesmic self-aggregation model yielded Kagg = 4.1±0.7×102 M–1 
and ∆Hagg = –7.3±0.6 kcal mol–1 (Fig. S3, S4). The thermogram for 
ligand–hybrid interaction indicated (at least) two types of binding 
site (Fig. 4). ITC data were analyzed using a model describing two 
consecutive binding events and a model describing two independent 
binding events; both models incorporated simultaneous ligand self 
aggregation (Scheme S1). Strong parameter correlation meant that 
the two types of site could not be quantified independently in a 
statistically-meaningful way. Nevertheless, analysis of parameter 
correlation plots concluded that the two binding events are a major 
binding site of 10 bp in combination with a minor binding event 
involving ligand association with (potentially-fraying) ends and 
gaps (supporting information). The overall binding stoichiometry is 
consistent with other experimental data for this system and 
simulated data based on binding parameters from ITC reproduced 
UV titrations well (Fig. S10). 
 
Figure 4. Integrated heat effects for titration of ligand 1 into 
poly(dA)·poly(rU) fitted using a model involving a major binding site in 
combination with a minor binding event (stoichiometry fixed at 
1:0.005).  
In conclusion, biarylpyrimidine 1 shows a strong preference for 
binding the poly(dA)·poly(rU) hybrid over all other duplex nucleic 
acid structures and as a DNA·RNA hybrid binder, inhibited RNaseH 
with IC50 = 29.5 ± 0.2 µM (Fig. 5).  
 
All experimental data indicated that each ligand occupies a 10 bp 
site; CD and AUC data unambiguously showed nucleic acid 
intercalation. The non-classical intercalator has flexibility of torsion 
angles between the three aromatic rings, this may contribute to the 
binding preference for the A-like hybrid as the ligand can 
accommodate closely to propeller-twisted base pairs.[6] Ligand 1 
also showed binding preferences for triplex and quadruplex nucleic 
acids. Moreover, triplex poly(dA)·[poly(dT)]2 also exists in an A-
like helix. It seems, therefore, that the binding preferences 
discovered are selection for the global A-like structure. However, 
ligand 1 does not bind to the other A-form structure in Fig. 1, the 
RNA duplex poly(rA)·poly(rU), an observation in contrast to major 
groove binding aminoglycosides where binding to equivalent RNA 
duplexes was strong.[7] An explanation may lie in the grooves and 
the dimensions of the ligand. The ligand possesses two cationic side 
chains and it may be postulated that one lies in the minor groove. 
Although the 2'-OH and associated solvation waters of a single 
RNA strand offer potential hydrogen bonding sites to the terminal 
ammonium functionality, these groups occlude the minor groove of 
the pure RNA duplex. Such steric constraints would also account for 
the reduced affinity of bulkier analogs of ligand 1 (Fig. S11). Indeed 
the hybrid minor groove appears inaccessible to all but the smallest 
groups: pentamidine, berenil, Hoechst 33258 and DAPI all failed to 
stabilize either of the hybrid duplexes in the melting of mixtures 
assay.[3] 
 
Binding rules for DNA·RNA duplexes are ill-defined and this study 
shows that naïve extrapolation from duplex binding models is 
inappropriate. The structural basis for the ~10 bp major binding site 
size is not yet clear but is equivalent to ~1 ligand per helical turn. 
The intercalator ethidium has been shown to exclude 3 or 7 bp when 
bound to the poly(dA)·poly(rU) hybrid.[8, 9] and precedent for long-
range transmission of binding effects over tens to hundreds of bp 
exists in the daunorubicin-driven Z→B conversion of 
[poly(dGdC)]2.[10]  
 
DNA·RNA hybrids and DNA triplexes both adopt structures 
intermediate between classic B-form DNA and A-form RNA. The 
correlation between binding data for ligand 1 and its analogs to 
these two structures is striking (Figs. 3 and S12) and demonstrates 
that the search for structure and sequence selective ligands for 
DNA·RNA hybrid duplexes should start with re-evaluation of DNA 
triplex-targeting compounds.  
 
Figure 5. Inhibition of the RNaseH digestion of poly(dA)·poly(rU) by 
compound 1; IC50 = 29.5 ± 0.2 µM. 
Experimental Section 
Compound 1 was synthesized as previously described.[11, 12] 
Oligonucleotides for CD and calorimetry were obtained from Midland 
Certified Reagent Co, Midland, TX (poly(dA), lot 111997, 126–1200 
nucleotides; poly(rU) lot 102197, 500–2600 nucleotides). All other 
oligonucleotides were purchased from Sigma, Milwaukee, WI, USA or 
Poole, UK. 
UV melting experiments were performed on a Cary 400Bio 
spectrophotometer equipped with Peltier. CD spectra were recorded 
on a Jasco J-810 spectropolarimeter with Peltier. ITC was performed 
on a Microcal VP-ITC calorimeter. Other spectra were recorded on a 
Jasco V-550 spectrophotometer and Tecan Safire2 microplate reader. 
Competition dialysis,[3, 13-16] melting of mixtures [3, 4] and RNaseH 
assays[3, 4] followed published protocols. 
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Job plots: the protocol followed that set out by Jenkins[17] but detected 
by UV. Mixtures of 1 and poly(dA)·poly(rU) to a summed 
concentration of 100 µM in BPES pH 6.00 were set up in duplicate on 
a 96 well microtitre plate. Reference solutions had buffer in place of 
nucleic acid. Spectra were recorded from 230-450 nm. Absorbance 
data for the drug maximum at 356 nm were extracted and the free 
drug absorbance subtracted from that of the drug-nucleic acid 
complex before plotting A356 vs. mole fraction of ligand 
CD Titrations: nucleic acid solutions in BPES pH 6.00 (1 ml) were 
prepared to have A257 ~0.8 and placed in a 1 cm pathlength quartz 
cuvette equipped with stirrer. Concentrated ligand solutions were 
prepared in the same buffer to minimize volume changes during 
titration. Aliquots were added until precipitation of the ligand-nucleic 
acid complex was seen. Raw data were corrected for dilution before 
plotting and analysis. 
ITC: all experiments were performed in BPES pH 6.00. 
Oligonucleotides were dissolved in buffer, dialyzed against buffer (3 
changes of solution) and the final dialysate used as solvent for all 
reactions and dilution of reagents. In a typical experiment, a solution 
of poly(dA)·poly(rU) (0.5 mM(bp)) was loaded into the calorimeter cell 
and ligand 1 (0.25 mM) loaded into the syringe; aliquots (10 µl) were 
added at intervals of 360 s. To determine the heats of dilution, a 
solution of 1 (5 mM) was titrated (15 µl aliquots, 360 s) into buffer. 
Other control titrations of buffer into nucleic acid and buffer into buffer 
were also performed. Data were treated in Origin (Microcal, Inc) to 
generate integrated heat effects per injection (∆h). These were 
analyzed using IC ITC following published procedures.[18, 19] Ligand 
self-aggregation parameters were determined from ligand dilution 
experiments and held constant in subsequent analyses of binding 
data. 
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Circular Dichroism 
 
 
 
Figure S1. Expansions of Figures 3c, f. 
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Analytical Ultracentrifugation (AUC) 
 
 
Figure S2. Sedimentation velocity AUC data. Solutions of poly(dA)·poly(rU) (0.7 ml, A257 =0.5, 0.0385 
mM(bp), BPES pH 6.00) were prepared alone and in the presence of ethidium (0.0385 mM) and ligand 
1 (0.0077 mM). Cell 1 (black), hybrid; Cell 3 (green), hybrid+1; Cell 2 (red), hybrid + ethidium. 
 
  
AUC Method 
 
Sedimentation velocity experiments were performed at a temperature of 20 oC and a rotor speed of 
50,000 rpm using a Beckman Optima XL-A analytical ultracentrifuge equipped with absorbance optics 
and an An60Ti rotor.  Following loading and before data collection, samples were allowed to equilibrate 
for 1 h after vacuum and temperature had been established.  Data were collected at 260 nm as a 
function of radial position.  Each centrifuge cell was scanned sequentially with zero time delay between 
scans until no further sedimentation was observed.  Primary sedimentation data were transferred to the 
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programs Sedfit and DCDT+ for analysis (1-5).  Solution density and viscosity were calculated from 
buffer composition as 1.00712 g/mL and 1.0225 cP, respectively, using the program Sednterp (6).  A 
value of 0.55 mL/g was assumed for the partial specific volume (7, 8).  Data were analyzed using Sedfit 
employing a continuous c(s) model with a range of 0.5 to 10 S and a confidence level of 0.68 (1 standard 
deviation).  Fitting was performed using alternating rounds of the simplex and Marquardt-Levenberg 
algorithms until there was no further decrease in rmsd.  Data were transformed into a differential 
apparent sedimentation coefficient distribution, g(s*), using DCDT+ and evaluated without model fitting.  
Data in the form of c(s) and g(s*) distributions were exported to Origin v7.0 (OriginLab Corporation, 
Northampton, MA) for graphing. 
 
 
 
References 
1. Schuck, P. (2008) SEDFIT (version 11.3b). National Institutes of Health, Bethesda, MD. Available 
from http://www.analyticalultracentrifugation.com/download.htm. 
2. Schuck, P. (2000) Size-Distribution Analysis of Macromolecules by Sedimentation Velocity 
Ultracentrifugation and Lamm Equation Modeling. Biophys. J. 78, 1606-19. 
3. Philo, J. S. (2007) DCDT+ (version 2.1.0.28333). John S. Philo, Thousand Oaks, CA. Available 
from http://www.jphilo.mailway.com/dcdt+.htm. 
4. Philo, J. S. (2000) A Method for Directly Fitting the Time Derivative of Sedimentation Velocity 
Data and an Alternative Algorithm for Calculating Sedimentation Coefficient Distribution 
Functions. Anal. Biochem. 279, 151-63. 
5. Philo, J. (2006) Improved methods for fitting sedimentation coefficient distributions derived by 
time-derivative techniques. Anal. Biochem. 354, 238-46. 
6. Hayes, D. B., Laue, T., and Philo, J. (2006) Sedimentation Interpretation Program (version 1.09). 
University of New Hampshire, Durham, NH. Available from 
http://www.jphilo.mailway.com/download.htm. 
7. Bloomfield, V. A., Crothers, D. M., and Tinoco, I., Jr. (2000) Nucleic Acids: Structures, Properties 
and Functions. University Science Books, Sausalito, CA. 
8. Hellman, L. M., Rodgers, D. W., and Fried, M. G. (2009) Phenomenological partial-specific 
volumes for G-Quadruplex DNAs. Eur. Biophys. J., Epub 24 February 2009. 
 
 9
ITC data analysis 
 
Binding models 
 
All ITC data was analysed using IC ITC. [1, 2] Parameters were defined as in Scheme S1 where L refers 
to ligand 1 and M (macromolecule) refers to the hybrid. 
 
Scheme S1 
 
Data analysis: ligand 1 self aggregation 
 
Ligand dilution experiments were analysed globally using an isodesmic self aggregation model (stepwise 
aggregation model) characterised by a single equilibrium constant and a single interaction enthalpy for 
the subsequent addition processes of a monomer to an existing aggregate, viz. Kagg and ∆Hagg. An 
isosdesmic self aggregation model was selected over the mathematically equivalent dimerization model 
because the structure of ligand 1 does not suggest that self aggregation stops at dimer formation. The 
isosdesmic self aggregation model accurately reproduces the experimental data (Figure S3).  
 
 
Figure S3: Integrated heat effects for dilution of a 5.0 mM ligand 1 solution in BPES, pH 6.0 at 20 °C (•) 
analysed globally in terms of an isosdesmic self aggregation model (solid red line). 
 
Error margins were determined as reported previously[2] (Figure S4). 
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Figure S4: Normalised Σdev2/dof as a function of optimizable variable values. 
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Data analysis: nucleic acid binding 
 
The data were initially analysed in terms of a model involving two different sets of independent binding 
sites, i.e. in terms of equilibria A1 and B1. The analysis resulted in fits that reproduce the experimental 
data well. However, analysis of the error margins showed that errors are typically large. Analysis of 
Σdev2/dof as a function of the values of the different variables shows why the error margins on the 
individual variables are large. Considerable parameter correlation allows various combinations of the 
different parameters to reproduce the experimental data (statistically) well. The most obvious example of 
this parameter correlation is provided by nA1 and nB1 (Figure S5) 
0.02
0.04
0.06
0.08
0.10
123
0.02
0.04
0.06
0.08
0.10
nor
m. S
dev
2/d
of
n
A1
nB1
 
Figure S5: Normalised Σdev2/dof as a function of values of nA1 and nB1. 
 
Figure S5 shows that the sum nA1+nB1 is well defined at 0.11. The individual parameters nA1 and nB1, 
however, can not be defined using the experimental data. 
 
Nevertheless, the observation that the SVD of the UV visible data indicated just two species, together 
with the Job plot showing a clean single peak, suggested that one of the following is the case: 1) there 
are two types of binding site which both contribute significantly to the total binding stoichiometry but have 
very similar (UV-visible and CD) properties and we could therefore expect similar binding constants and 
enthalpies of interaction or 2) there are two different binding sites but one of these contributes 
significantly more towards the total binding stoichiometry than the other, resulting in the low 
stoichiometry binding site being practically invisible by the various spectroscopic techniques. 
 
 
1. Two types of similar binding site 
 
The extreme, but representative, example of this situation involves two very similar binding sites with 
identical binding site sizes. For the present case, this corresponds to stoichiometries of 0.056 (vide 
supra). This binding site size corresponds to approximately two helical turns per ligand, which seems 
rather considerable for ligand 1. A possible interpretation involves the binding of one ligand molecule to a 
site equivalent to one helical turn. This first binding event then affects one further helical turn of 
neighbouring bp to form a slightly different second binding site. Effectively, this corresponds to a 
description involving slight anti-cooperativity in ligand binding. The appropriate model to analyse this 
type of data would be the KA1-KA2 model where the first binding event “creates” a second binding site. An 
unrestricted fit of the data in terms of the KA1-KA2 model shows strong parameter correlation between nA1 
and nA2 (Figure S6). 
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Figure S6: Normalised Σdev2/dof as a function of value of nA1 and nA2. 
 
In order to model a system with two binding sites of (nearly) identical sizes, nA1 was restricted to 0.0506 
in a subsequent analysis, yielding optimised parameters as illustrated in Figure S7. 
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Figure S7: Normalised Σdev2/dof as a function of variable value for KA1, ∆HA1, KA2 and ∆HA2, nA2 for nA1 
restricted to 0.056. 
 
Figure S7 shows that ∆HA1, KA2, ∆HA2, and nA2 are now reasonably well defined (although, admittedly, the 
plots of the normalised Σdev2/dof level off just below 2). The best fit parameters are KA1 =  2.5×106 M-1, 
KA2 =  5.1×105 M-1, ∆HA1 = -1.36×104 cal mol-1, ∆HA2 = -1.79×104 cal mol-1, nA2 =  5.7×10-2. 
 
2. One major binding site and one minor binding site 
 
The alternative interpretation of the ITC data involves one binding site with a size corresponding to one 
helical turn and a second binding site with a stoichiometry significantly less than one per helical turn. The 
only logical binding site type presenting binding sites with an apparent site size significantly larger than a 
single helical turn are sites corresponding to strand-ends. To decide which of the two binding events, A1 
or B1, is most likely to correspond to ligand 1 binding to (potentially fraying) ends and/or gaps, we 
analysed the correlation between stoichiometry and interaction enthalpy for both binding events (Figure 
S8). 
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Figure S8: Normalised Σdev2/dof as a function of values of nA1 and ∆HA1 (left) and as a function of nB1 
and ∆HB1 (right).  
 
Figure S8 (left) shows that the “valley” defined by the normalised Σdev2/dof as a function of values of nA1 
and ∆HA1 has a smooth edge defining the minimum value for ∆HA1 for each value of nA1. The edge 
defining the maximum value of ∆HA1 for each value of nA1 is ragged, however, indicating that this region 
of parameter space was not sampled sufficiently. This was confirmed by further independent extensive 
simulated annealing runs which resulted in further graphs of the type of Figure S8 (left). For these 
graphs, the lower edges of the valleys (defining the minimum values for ∆HA1) were identical to that 
shown in Figure 8 (left) while the edges defining the maximum values for ∆HA1 were not reproducible. 
This indicates that only the minimum values for ∆HA1 are well-defined. Similarly, for binding event B1, 
only the maximum values for ∆HB1 are well-defined.  
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Figure S9: Normalised Σdev2/dof as a function of variable value for KA1, ∆HA1, nA1, KB1 and ∆HB1 for nB1 
restricted to 0.005. 
 
Figure S9 shows that KA1 and KB1 are reasonably well defined but this is not the case for the interaction 
enthalpies (in fact, ∆HB1 is unrealistically negative, but this is strongly dependent on the choice for nB1 as 
shown by Figure S8). The best fit parameters are KA1 =  9.97×105 M-1, ∆HA1 = -4.13×102 cal mol-1, nA1 =  
1.07×10-1, KB1 =  8.42×105 M-1, ∆HB1 = -3.49×105 cal mol-1. 
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Nevertheless, Figure S8 shows that the behaviour of the binding enthalpy at low stoichiometry for the 
two binding events is rather different. For low values of nA1, (the minimum value for) ∆HA1 becomes 
increasingly less exothermic and eventually even endothermic. Event A1 has been defined to be the first 
binding event, i.e. it corresponds to the highest binding constant, and would therefore have to be 
significantly, if not completely entropy driven. Binding event A1 is therefore unlikely to correspond to the 
low stoichiometry binding event. For low values of nB1, on the other hand, (the maximum value for) ∆HB1 
becomes increasingly exothermic. Binding event B1 therefore appears a reasonable candidate for ligand 
binding to potentially frayed ends: the interaction is more endothermic than the first binding event and 
therefore has a less favourable entropy of interaction. This fits well with the hypothesis that this binding 
event corresponds to ligand binding to potentially-frayed strand ends. 
 
Based on an average strand length for poly(dA) of 200 (126-1200 nucleotides, majority 125-350) and the 
fact that the poly(rU) strands are significantly longer, an estimate for stoichiometry nB1 is 0.005 ligands 
per bp. Although Figure S8 predicts that ∆HB1 will not be well defined for this choice, the data was re-
analysed using a value of 0.005 for nB1 yielding optimised parameter values as illustrated in Figure S9. 
 
 
Simulated UV-visible titrations 
Using the best fit parameters for the model involving two similar binding sites and the model involving 
one major and one minor binding site, species concentrations were calculated for total concentrations 
corresponding to those used for the UV-visible titration and these were compared with the experimental 
data for the UV-visible titration (Figure S10). 
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Figure S10: Calculated concentrations [Ligand 1]A1+A2 for the model involving two similar binding sites 
A1 and A2 (left), calculated concentrations [Ligand 1]A1 for the model involving one major and one minor 
binding site (middle) and experimental UV-visible titration (right). Lines are fits to a multiple independent 
binding sites model. 
 
Fitting the simulated data, i.e. assuming a linear UV-visible response with species concentration, to a 
multiple independent identical binding sites model yields binding constants of 10.9×105 M-1 and 9.6×105 
M-1 for the simulated data involving two similar binding sites and for the simulated data for a major and a 
minor binding site, respectively. Both values compare favorably with the experimental binding constant of 
(8.3±2.7)×105 M-1. The binding stoichiometry of 8.9 base pairs per ligand as found for both sets of 
simulated data similarly is in agreement with the value of 8.0 as found for the experimental UV-visible 
titration. Hence, comparison with the data from the UV-visible titration does not allow us to select one of 
the models. The observation that simulated data for an equilibrium system involving two different types 
of binding site can be reproduced extremely well in terms of a model involving a single type of 
independent binding sites is in line with our previous observations.[2]  
 
Summary 
The ITC data do not allow us to distinguish between the two possible combinations of interactions 
because the two equilibria cannot be satisfactorily separated. This situation resembles the case where 
data have been collected at a low Wiseman-c. For the case of consecutive binding events, however, the 
“separability” of binding events depends on the relative Wiseman-c values for the different equilibria and 
these cannot be optimised through changes in macromolecule concentration 
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Nevertheless, the relative merits of the two binding models can be compared. In this respect, the model 
involving two similar binding events suffers from the structural interpretation involving ligand 1 binding to 
an entire helical turn while affecting binding over a further full helical turn. The model involving a major 
and a minor binding site, on the other hand, has the advantage that it provides a more realistic structural 
interpretation of the different binding events in terms of a major binding site involving approximately 10 
bp and a minor binding site involving ligand 1 binding to (frayed) ends and gaps.  
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